YD Bio Ltd (YDES) Form 10-K Annual Reports
YD Bio Ltd (YDES) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: YDES
CIK: 2011674
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJulia Zhang
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-09-30 | 4 Filing | 0001213900-26-107184 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-09-30 | 4 Filing | 0001213900-26-107185 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001213900-26-100506 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | OWNERSHIP DOCUMENT | 0001213900-26-098775 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 Filing | 0001213900-26-098030 | View SEC Doc Filr Page |
| 424B3 | 2026-09-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-095816 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095815 | View SEC Doc Filr Page |
| 424B3 | 2026-08-11 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-087714 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-087713 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001213900-26-074188 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001213900-26-074187 | View SEC Doc Filr Page |
| EFFECT | 2026-05-29 | — | EFFECT Filing | 9999999995-26-001807 | View SEC Doc Filr Page |
| POS AM | 2026-05-26 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-26-061106 | View SEC Doc Filr Page |
| 6-K | 2026-05-01 | 2026-04-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-050525 | View SEC Doc Filr Page |
| 20-F | 2026-04-30 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-050282 | View SEC Doc Filr Page |
| 3/A | 2026-04-20 | 2026-03-18 | 3/A Filing | 0001213900-26-045436 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | 4 Filing | 0001213900-26-039317 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | 4 Filing | 0001213900-26-039316 | View SEC Doc Filr Page |
| 3 | 2026-04-02 | 2026-03-18 | 3 Filing | 0001213900-26-039309 | View SEC Doc Filr Page |
| 3 | 2026-04-02 | 2026-03-18 | 3 Filing | 0001213900-26-038853 | View SEC Doc Filr Page |
| 3 | 2026-03-30 | 2026-03-18 | 3 Filing | 0001213900-26-036389 | View SEC Doc Filr Page |
| 3 | 2026-03-27 | 2026-03-18 | 3 Filing | 0001213900-26-035493 | View SEC Doc Filr Page |
| 3 | 2026-03-26 | 2026-03-18 | 3 Filing | 0001213900-26-034694 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030219 | View SEC Doc Filr Page |
| 424B3 | 2026-02-27 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-021167 | View SEC Doc Filr Page |